Ironwood pharmaceuticals stock
WebFeb 24, 2016 · Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that a new drug application (NDA) seeking approval of linaclotide for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) in Japan was filed with the Japanese Ministry of Health, Labor and Welfare by Astellas Pharma Inc., Ironwood’s partner for …
Ironwood pharmaceuticals stock
Did you know?
WebApr 13, 2024 · A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Ironwood Pharmaceuticals Inc.’s current trading price is … WebIronwood Pharmaceuticals, Inc. Follow Share $10.88 After Hours: $10.88 (0.00%) 0.00 Closed: Apr 6, 4:01:14 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to …
WebMar 10, 2024 · Ironwood Pharmaceuticals, Rigel Pharmaceuticals and FibroGen were among the biotech stock movers in premarket trading on Monday. IRWD RIGL FGEN. … WebApr 10, 2024 · Ironwood Pharmaceuticals (NASDAQ:IRWD) has a market capitalization of $1.62 billion and generates $410.60 million in revenue each year. The biotechnology …
WebIronwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases. Cambridge, Massachusetts, United States 501-1000 Post-IPO Debt Public www.ironwoodpharma.com 24,278 Actively Hiring - View All Jobs Highlights Stock Symbol NASDAQ:IRWD Total Funding Amount $634M Contacts 298 WebApr 10, 2024 · Ironwood Pharmaceuticals Inc. shares surged 3.5% in premarket trade Monday, after the company reported positive results in mid-stage trials of a treatment for …
WebIronwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. Subscribe . ... Ironwood Pharmaceuticals (IRWD) Stock Key Data. Summary Additional Data Analysts Historical Quotes.
WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … ipad indicates not chargingWebApr 12, 2024 · To see how Ironwood Pharmaceuticals Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: IRWD stock’s performance was 0.37% in the latest trading, and -15.33% in the past year, while AstraZeneca PLC (AZN) has traded 0.15% on the day and positioned 1.65% higher than it was a year ago. open new paypal accountWebSep 27, 2024 · Oleg Elkov/iStock via Getty Images. Investment Thesis. Ironwood Pharmaceuticals (NASDAQ:IRWD) is a gastrointestinal health care company that is best known for its market leading product, LINZESS ... ipad infuse hdrWebApr 13, 2024 · A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Ironwood Pharmaceuticals Inc.’s current trading price is -15.88% away from its 52-week high, while its distance from the 52-week low is 9.46%. The stock’s price range during this period has spanned from $9.73 to $12.66. ipad inductive chargingWebMar 9, 2024 · Ironwood Pharmaceuticals stock has received a consensus rating of hold. The average rating score is and is based on 1 buy ratings, 3 hold ratings, and 0 sell ratings. ipad infected warningWebDec-23-21 11:15PM. Ironwood Pharmaceuticals Inc (IRWD) CEO Thomas A Mccourt Sold $528,591 of Shares. GuruFocus.com. Dec-11-21 03:16PM. open new pdf fileWebMar 24, 2024 · Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. open new personal email account gmail